Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Copegus

Copegus is a medicine containing the active ingredient(s) ribavirin. On this page you will find out more about Copegus, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: ribavirin

Information for medicine and pack size:
Copegus 200 mg film-coated tablet, 42

Consumer Medicine Information leaflet:

No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.

What this medicine is for

COPEGUS is indicated in combination with PEGASYS (peginterferon alfa-2a) or other interferon alfa agents for the treatment of chronic hepatitis C in previously untreated (treatment-naive) patients. COPEGUS in combination with PEGASYS is also indicated for the treatment of patients who have failed preivous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination therapy with ribavirin. COPEGUS is also indicated in combination with PEGASYS for the treatment of chronic hepatitis C in patients with clinically stable human immunodeficiency virus (HIV) who have previously not received interferon therapy. Patients must be 18 years of age or older and have compensated liver disease.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Light pink to pink, flat, oval film-coated tablets with "RIB" & "200" engraved on one side and "ROCHE" on the other.
Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
112 tablets: Prescription Only Medicine, or Prescription Animal Remedy
140 tablets: Prescription Only Medicine, or Prescription Animal Remedy
168 tablets: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Bottle
Storage temperature Store below 30 degrees Celsius
Storage conditions No information available
Life time 4 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 3 results

Pegasys RBV Combination Therapy Combination pack - myDr.com.au

Pegasys RBV Combination Therapy Combination pack - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Pegasys Solution for injection - myDr.com.au

Pegasys Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Pegasys (peginterferon alfa-2a) information | myVMC

Pegasys (peginterferon alfa-2a) is an interferon medicine used to treat viral infections of the liver such as hepatitis B or C.

Read more on myVMC – Virtual Medical Centre website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback